Xencor Inc·4

Feb 16, 6:25 PM ET

Foster Paul A 4

4 · Xencor Inc · Filed Feb 16, 2018

Insider Transaction Report

Form 4
Period: 2018-02-16
Foster Paul A
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Stock Option (right to buy)

    2018-02-165,00048,064 total
    Exercise: $0.59Exp: 2022-09-25Common Stock (5,000 underlying)
  • Sale

    Common Stock

    2018-02-16$25.01/sh5,000$125,0502,419 total
  • Exercise/Conversion

    Common Stock

    2018-02-16$0.59/sh+5,000$2,9507,419 total
Footnotes (2)
  • [F1]Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted November 23, 2015.
  • [F2]The stock option is fully vested.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION